The incumbent is a single global point of contact who manages the entire supply chain for assets being developed under the Alternative Development Program (ADP) and ADP-like programs. This includes but is not limited to the entire global supply chain for investigational drug, comparators and placebo, ancillary supplies such as syringes or other delivery devices and Interactive Voice Response Systems as they pertain to randomization of patients and management of study medication.